15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Progyny Inc, 8 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $26.00 to $40.00, a moderate spread. The average target of $31.89 sits 4% above the current $30.79. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 7 to 8 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.52 next quarter toward $2.25 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Strong Buy
Strong Buy00%
Buy889%
Hold111%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Progyny Inc.
As of Jul, 8 of 9 firms rate PGNY a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PGNY EPS & revenue forecast
EPS · NEXT QUARTER
$0.52
Range $0.50 – $0.55 · 8 analysts · +16% YoY
Next period, 8 analysts expect Progyny Inc to earn $0.52 a share (range $0.50 – $0.55), versus $0.45 a year earlier. Full-year consensus is $2.06, growing to $2.25 the year after.
REVENUE · NEXT QUARTER
$350.6M
Range $343.3M – $358.4M · 8 analysts · +12% YoY
Revenue is expected to reach $350.6M (range $343.3M – $358.4M), +11.9% year-over-year. Full-year consensus is $1.4B, rising to $1.5B next year.
Top analysts covering Progyny Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PGNY.
#1
Constantine Davides
JMP Securities · Rank #225
Buy
$31.00+0.7% to target
Overall win rate
34%
+ Follow
#2
Scott Schoenhaus
Keybanc · Rank #345
Buy
$35.00+13.7% to target
Overall win rate
29%
+ Follow
#3
Richard Close
Canaccord Genuity
Buy
$36.00+16.9% to target
Coverage
—
+ Follow
#4
Jailendra Singh
Truist Securities
Buy
$33.00+7.2% to target
Coverage
—
+ Follow
#5
David Larsen
BTIG
Buy
$40.00+29.9% to target
Coverage
—
+ Follow
PGNY stock forecast FAQ
What is PGNY's average 12-month price target?+
The 9 analysts with a live target average $31.89 for Progyny Inc over the next 12 months, ranging from a $40.00 high to a $26.00 low.
Is PGNY stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 9 analyst ratings, 8 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PGNY?+
The Street-high target is $40.00 (BTIG), and the Street-low is $26.00 (JP Morgan). The average of all 9 active targets is $31.89.
How many Wall Street analysts cover PGNY?+
9 analysts have an active rating on Progyny Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering PGNY?+
Among analysts who currently cover PGNY, Constantine Davides of JMP Securities has the strongest overall Quantellect track record (Rank #225). Their current call is Buy with a $31.00 target.
What is Progyny Inc's projected EPS for next quarter?+
The consensus estimate is $0.52 per share (range $0.50 – $0.55) across 8 analysts. Full-year EPS is projected at $2.06, rising to $2.25 the following year.
How much revenue is Progyny Inc expected to report next quarter?+
Consensus revenue is $350.6M (range $343.3M – $358.4M). Full-year revenue is projected at $1.4B, growing to $1.5B next year.
Have analysts been upgrading or downgrading PGNY lately?+
As of Jul, 8 of 9 firms rate PGNY a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PGNY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
